Medical RWA Quest: How On-Chain Assets Unlock New Value Frontiers in Healthcare — China Innovative Medical Assets Salon | Episode 3
Recently, companies such as Meinian Onehealth, Huajian Medical, and Hybio Pharmaceutical have been continuously exploring medical Real-World Assets (RWA). From R&D pipelines to equipment revenue rights and service revenue sharing, assets across the entire healthcare sector are accelerating their on-chain integration.
Meanwhile, BGI Win-Win and Huajian Medical have jointly launched a special fund dedicated to medical Real-World Assets (RWA), focusing on the investment and incubation of tokenized medical assets. This initiative further propels the evolution of medical RWA from isolated corporate pilots toward collaborative development within an industrial ecosystem, opening new horizons for value reconstruction and efficient circulation of medical assets.
VCBeat DeepVBInsighta trend,Focusing on hot topics and core issues in innovative asset transactions, and centering on key buyer groups such as strategic, financial, and industrial investors, we will launch the online live-streaming series “China Innovative Healthcare Asset Lounge.”，In-depth analysis of the underlying logic of transactions, deconstruction of practical case studies, and sharing of cutting-edge market insights and hands-on experience to build an efficient platform for knowledge exchange, target selection, and resource sharing for buy-side participants.
On Sunday, September 28, at 15:00, the third session of the “China Innovative Healthcare Assets Lounge” Deal Roundtable, jointly hosted by BGI Win-Win, Meinian Onehealth, and VCBeat, invitedLiu Yu, Managing Partner at BGI Win-Win; Cai Mingzi, Assistant to the Chairman of Meinian Onehealth; and Huang Min, Partner at Shenzhen Xunce Technology Co., Ltd. and CEO of Beijing Huayin Shangce Data Technology Co., Ltd.Three guests centered around[Medical RWA Challenge: How On-Chain Assets Unlock New Frontiers in Healthcare Value]】MasterThrough in-depth thematic discussions, we provide the buy-side community with actionable trading logic and insights into frontier sector allocation, establishing a “strategic think tank” for healthcare innovation asset transactions. This empowers buyers to efficiently capture high-quality asset deal opportunities, bridging China’s healthcare innovation assets with global investors.
Host: Zhang Sang
Guest: Cai Mingzi
Assistant to the Chairman, Meinian Onehealth Healthcare Group
Joined Meinian Onehealth in June 2025, assisting the Group with strategic cooperation and capital operations, and facilitating leapfrog development in ecosystem building, technological innovation, and capital empowerment. Previously served as Chief Healthcare Analyst at a securities firm’s research institute, with 10 years of experience in healthcare industry research. Recipient of awards from prestigious evaluations including the China Securities Industry Analysts’ Golden Bull Award, Sina Finance’s Golden Qilin Awards, and the Crystal Ball Awards.
Guest: Huang Min
Partner, Shenzhen Xunce Technology Co., Ltd.
CEO, Beijing Huayin Shangce Data Technology Co., Ltd.
Chief Expert of the China Big Data and Intelligent Computing Industry Alliance, Director of the Big Data Application Branch of the China Software Industry Association, and Think Tank Expert for the Beijing International Big Data Exchange, Shanghai Data Exchange, and Shandong Data Exchange.
20+ years of experience in data-driven operations. Possesses macro-level industry insights, with expertise in the commercial implementation of data and the securitization of data assets. Capable of comprehensively and accurately analyzing and grasping the operational dynamics and risk characteristics across all segments of the industry value chain, demonstrating a profound understanding of the data industry.
Guest: Liu Yu
Managing Partner, BGI Win-Win Industry Fund
With 20 years of experience in the commercialization of scientific and technological achievements, incubation of start-ups, and investment management of early- to mid-stage projects. From 2001 to 2009, served as Director of the Shareholding Reform Center at the Shenzhen International High-Tech Property Rights Exchange. In 2007, initiated and established "Nanhai Chengzhang," the first limited partnership equity investment fund in China, and participated in its co-management. In 2009, founded Hua’ao Capital (now renamed Aoyin Capital). The Hua’ao Phase I, Phase II, and Phase III funds, under his lead management, have completed full exit and liquidation, delivering excellent performance returns. In 2017, partnered with BGI Group, a leader in genetic technology, to establish BGI Win-Win, focusing on biotechnology investments. Representative investment cases include Snibe Co., Ltd. (300832.SZ) and Biokangtai (300601.SZ).
China Innovative Healthcare Asset Lounge - Transaction Roundtable
“China’s Innovative Healthcare Asset Lounge” is an online live-streaming program launched by VCBeat, strategically positioned to “connect China’s innovative healthcare assets with global buyers.” The program focuses on high-quality asset transactions in fields such as innovative drugs, high-end medical devices, and digital health, aiming to build a professional platform for “showcasing, communication, and matchmaking” tailored to strategic, financial, and industrial buyers. With the goal of “unlocking the value of China’s innovative assets and facilitating efficient transactions,” the program helps buyer groups capture opportunities in high-quality assets through precise supply-demand matching, analysis of transaction logic, and sharing of practical experience. Meanwhile, it promotes the commercialization and retention of domestic innovative assets, contributing to the ecosystem development of the Global Life and Health Innovative Asset Buyer Alliance.
“Deal Roundtable,” a sub-column of “China’s Innovative Healthcare Asset Lounge,” focuses on the strategies, trends, and regulations governing transactions in innovative healthcare assets. Adopting a “buyer-centric perspective,” it invites members of the Buyer Alliance, seasoned investors, and experts from law firms and investment banks to engage in dialogues around hot-button issues and pain points in deal-making. By combining “benchmark case analyses” with “strategic insights,” the column provides buyers with actionable transaction logic and references for positioning in frontier sectors, thereby establishing a “strategic think tank” for innovative healthcare asset transactions and empowering buyers to efficiently capture high-quality deal opportunities.
Scan the QR code to reserve a spot for the live stream